TELO

Telomir Pharmaceuticals
TELO

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$47.78M
EV
$47.11M
Shares Outstanding
32.28M
Beta
-

Wall Street View

Analyst Rating
NO_OPINION
Analyst Target Price
$15.50
P/E undefinedE
-
P/Revenue undefinedE
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Telomir Pharmaceuticals, Inc.

gainify
TELO

Telomir Pharmaceuticals, Inc.

TELO

Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human stem cells. The company develops TELOMIR-1, a novel small molecule being developed to function as an oral in...

Sector

Healthcare

Industry

Biotechnology

CEO

Aminov, Erez

Employees

IPO Date

2019-04-09

Headquarters

855 N Wolfe Street, Suite 601, Baltimore, Maryland, 21205, United States

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.